Literature DB >> 1280239

Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM.

E R Lampeter1, T K Kishimoto, R Rothlein, E A Mainolfi, J Bertrams, H Kolb, S Martin.   

Abstract

Serum levels of recently discovered circulating forms of adhesion molecules, ICAM-1 and L-selectin, were found to be elevated in IDDM patients and in subjects at risk for developing IDDM compared with 100 normal, nondiabetic blood donors. Both adhesion molecules were determined by sandwich ELISA. Serum concentrations of either clCAM-1 or cL-selectin were > 2SD of normal mean in 10 of 14 recent-onset IDDM patients (P < 0.05). Serum levels of clCAM-1 and cL-selectin did not correlate. In first-degree relatives, elevated adhesion molecule levels were observed in the 6 ICA+ individuals and in the ICA- individuals all (n = 14) with a genetic risk of IDDM (sharing HLA-DR3 and/or-DR4 with the diabetic relative) but not in the HLA-DR3- and/or -DR4- relatives (n = 13). We conclude that elevated clCAM-1 and cL-selectin levels occur independently of ICA status and probably reflect ongoing immune processes in recent-onset IDDM patients and first-degree relatives at risk for IDDM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280239     DOI: 10.2337/diab.41.12.1668

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes.

Authors:  Shayne C Barlow; Will Langston; Kametra M Matthews; John H Chidlow; Christopher G Kevil
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

2.  Levels of soluble Fc gammaRIII correlate with disease severity in sepsis.

Authors:  A C Muller Kobold; J G Zijlstra; H R Koene; M de Haas; C G Kallenberg; J W Tervaert
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

3.  Soluble adhesion molecules in pre-clinical Type 1 diabetes: a prospective study.

Authors:  A M Toivonen; P Kulmala; K Savola; H K Akerblom; M Knip
Journal:  Diabetologia       Date:  2003-04-09       Impact factor: 10.122

4.  The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha.

Authors:  S García-Vicente; A Abella; N Viguerie; A Ros-Baró; M Camps; X Testar; M Palacín; A Zorzano; L Marti
Journal:  J Physiol Biochem       Date:  2005-06       Impact factor: 4.158

5.  Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus.

Authors:  A Accardo-Palumbo; G Triolo; E Giardina; M C Carbone; A Ferrante; G Triolo
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

6.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

7.  Foveolar choroidal hemodynamics in proliferative diabetic retinopathy.

Authors:  Lisa S Schocket; Allison J Brucker; Rachel M Niknam; Juan E Grunwald; Joan DuPont; Alexander J Brucker
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

8.  Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathy.

Authors:  J R MacKinnon; R M Knott; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

9.  Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.

Authors:  A E Heufelder; R S Bahn
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

10.  Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.

Authors:  N Itoh; T Hanafusa; A Miyazaki; J Miyagawa; K Yamagata; K Yamamoto; M Waguri; A Imagawa; S Tamura; M Inada
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.